1
2
3
4
Por ZOU, YOU, WANG, YAN, WANG, SHUI-BIN, KONG, YONG-GANG, XU, YU, TAO, ZE-ZHANG, CHEN, SHI-MING
Publicado no Exp Ther Med (2016)
Obter o texto integralPublicado no Exp Ther Med (2016)
Obter o texto integral
Obter o texto integral
Artigo
5
Por Zou, You, Deng, Yu-Qin, Xiao, Chang-Wu, Kong, Yong-Gang, Xu, Yu, Tao, Ze-Zhang, Chen, Shi-Ming
Publicado no Pak J Med Sci (2015)
Obter o texto integralPublicado no Pak J Med Sci (2015)
Obter o texto integral
Obter o texto integral
Artigo
6
Por Yang, Rui, Tao, Ze-Zhang, Huang, Mao-Ling, Zheng, Yong-Fa, Dai, Meng-Yuan, Zou, You, Chen, Shi-Ming
Publicado no Am J Transl Res (2018)
Obter o texto integralPublicado no Am J Transl Res (2018)
Obter o texto integral
Artigo
7
Por Zou, You, Fang, Fang, Ding, Yong-Jun, Dai, Meng-Yuan, Yi, Xing, Chen, Chen, Tao, Ze-Zhang, Chen, Shi-Ming
Publicado no Mol Med Rep (2016)
Obter o texto integralPublicado no Mol Med Rep (2016)
Obter o texto integral
Obter o texto integral
Artigo
8
Por Liu, Xiulan, Zhou, Zhongshi, Cheng, Qi, Wang, Hongjie, Cao, Hui, Xu, Qianqian, Tuo, Yali, Jiang, Li, Zou, You, Ren, Hongyu, Xiang, Ming
Publicado no Cell Death Dis (2017)
Obter o texto integralPublicado no Cell Death Dis (2017)
Obter o texto integral
Obter o texto integral
Artigo
9
Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas
Por Teng, Fei, Guo, Meng, Liu, Fang, Wang, Ce, Dong, Jiayong, Zhang, Lei, Zou, You, Chen, Rui, Sun, Keyan, Fu, Hong, Fu, Zhiren, Guo, Wenyuan, Ding, Guoshan
Publicado no Oncotarget (2016)
Obter o texto integralPublicado no Oncotarget (2016)
Obter o texto integral
Obter o texto integral
Artigo